Welcome to our weekly blog post recapping the latest episode of the Kentucky NORML Livestream. We are thrilled to bring you the highlights and insights from our weekly updates..
Our Livestream series serves as a platform to discuss important topics, debunk myths, and promote evidence-based information surrounding medical cannabis.
In this recap, we will provide you with a overview of the key takeaways from the livestream, ensuring that you stay informed about the latest developments in medical cannabis advocacy and policy. We have also embedded the recorded video of the Livestream, allowing you to watch the discussion firsthand and engage with the content directly.
We believe in empowering individuals with knowledge and fostering a community of informed advocates. We invite you to explore the additional resources mentioned in the Livestream, such as relevant articles, studies, and websites, to deepen your understanding of medical cannabis.
Join us in the conversation by leaving your comments and questions in the video chat or directly on this post. Your active participation helps us create a dynamic and inclusive community dedicated to promoting sensible cannabis policy and advancing patient care.
Together, let's continue to explore, educate, and advocate for a more compassionate and well-informed approach to cannabis policy and its impact on patient well-being.
Watch the embedded video below and let's embark on this enlightening journey together!
The first article we discussed was from WHAS11 called Medical marijuana: Does it make business sense?
Good news from CHFS about the speed at which they are forming Kentucky's medical cannabis program.
"The Cabinet for Health and Family Services (CHFS) is moving quickly with the goal to have the program ready much earlier should the General Assembly decide to speed up its timeline. We are currently engaging with internal partners, such as ABC, that may help CHFS in similar ways that were done for Delta 8.” – Susan Dunlap/CHFS Office of Public Affairs
Marijuana and Opioid Inpatient Research Study
Researchers with the University of Kentucky Center on Drug and Alcohol Research are conducting a marijuana and opioid research study.
• Ages 18 to 50
• Individuals who use marijuana and opioids; do not get sick when they stop using opioids (not physically dependent on opioids)
• Inpatient study (live at the UK Hospital) for about 4.5- 5 weeks
• Participants will be administered vaporized marijuana and intranasal opioids (alone and in combination) during the study to determine their effect on your mood and body.
• Not a treatment study – not for individuals who want to quit using opioids or marijuana
• First step to determining your eligibility is to do a confidential phone screen (Call: 1-866-933-4859 or Text: 859-285-0346).
• Usually 2-3 screening visits: During in-person screening visits we will ask you questions about your drug use and health, collect breath and urine samples for alcohol and drug testing (these urine samples will be observed by a staff member), collect blood for laboratory testing and an ECG to check your heart.
• Transportation may be provided, or you may be compensated for travel.
• Screening: $50 per visit
• You may receive gas/travel payment
• Inpatient Payment: If you enroll in the study, you will be paid $60 per night while you are in the hospital. If you complete the entire study, you will get a completion bonus of an extra $60 for each night that you were in the study ($120/night for completers).
• Follow-up appointment (2-4 weeks after study completion): $25
• Total earnings are approximately: $4000
For more information:
UK Cannabis Center awards 1st faculty pilot grants
Four researchers have been selected for grants and represent the College of Nursing, College of Public Health, College of Pharmacy and the Martin School of Public Policy and Administration. Awards in the amount of $75,000-$100,000 will fund studies for a period of 14 months.
NORML's Marijuana Research Library
Since 1970, NORML has served as a clearinghouse for marijuana-related information. Much of this information, including transcripts of NORML’s testimony before Congress and state legislative committees, is now available online in NORML’s Library.
UK Cannabis Center announces
next expert featured in seminar series
The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science. This series will give UK students, faculty and the general public the chance to hear cutting-edge cannabinoid science across a wide variety of specialties (medicine, pharmacology, public health, impaired driving science, agriculture, legal and social justice).
The next seminar will highlight the work of Ashley Brooks-Russell, Ph.D., associate professor of community and behavioral health, and director of the Injury and Violence Prevention Center at the Colorado School of Public Health. She has published findings from more than 25 studies related to cannabis.
Brooks-Russell will present findings from her study, “Cannabis Impaired Driving: Policy Challenges and Emerging Solutions.”
The seminar will be held 1-2 p.m. EST Tuesday, June 13, via Zoom. Anyone is welcome to attend. Register online here.
Kentucky NORML is pleased to announce its participation as an exhibitor at the prestigious 2023 Ohio/Kentucky CannaTech Expo & Conference. Additionally, we are proud to share that Lauren Bratcher, Deputy Director of our organization, will be a featured speaker during the event.
We invite all those interested in attending this conference in Cincinnati to contact us, as we are offering an exclusive promotional code for our members. #cannatechexpos
B2B Cannabis Industry Conference and Expo. The largest Cannabis Business Expo and Conference in Ohio. As Ohio and Kentucky continue to evolve in the Cannabis business, hemp, laws, and regulations, you can join thousands of industry professionals to gain information on this profitable and expanding market.
That's all for this week. Continue to join on us on Thursdays at 7/8 for updates and make sure you sign up for email updates!
If you appreciate our work and want to support it, please visit kynorml.org/support